HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer. (Q38729418)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Ulrich Wellner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

author name string

Judith L Dibbern

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Matthias Reeh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jameel T Miro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Tung Y Tsui

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jakob R Izbicki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Cenap Güngör

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Yogesh K Vashist

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

publication date

1 March 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

369-380

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

Adjuvant and neoadjuvant treatment in pancreatic cancer

28 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Redefining the R1 resection in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Resection margins and R1 rates in pancreatic cancer--are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Metastatic pancreatic cancer: old drugs, new paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces or

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Hsp90 activation and cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

The Hsp90 chaperone machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Heat shock protein 90: the cancer chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Heat shock proteins in cancer: chaperones of tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Anticancer activity of HS-527, a novel inhibitor targeting PI3-kinase in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Blocking oncogenic Ras signaling for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of th

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Overexpression and localization of heat shock proteins mRNA in pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Heat shock proteins: endogenous modulators of apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Heat shock proteins: regulators of stress response and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

Modulation of Akt kinase activity by binding to Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-016-1332-4

10.1007/S10495-016-1332-4

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27878398%20AND%20SRC:MED&resulttype=core&format=json

release_hf3hqw3suramfgzxbasxenrc2y

28 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hf3hqw3suramfgzxbasxenrc2y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference